Company / Income Tax
Merck & Co. Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$2.8B
FY2025
5-year range
$1.5B / $2.8B
FY2021-FY2025
Trend
+0.0%
vs FY2024
Sector context
#3 of 204
Health Care
What the data says
Among 204 Health Care companies, Merck & Co. is in the bottom 1% for income tax. Income Tax has fluctuated over the past 10 years, ranging from $718M in FY2016 to $4.1B in FY2017.
Based on SEC 10-K filings.
$2.8B in FY2025 with a 5-year CAGR of +15.9%. Ranks 3rd among 204 companies in Health Care.
Increased from $1.5B to $2.8B over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- +13.5%
- 5-Year CAGR
- +15.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 204This company $2.8B Sector average $118.7M
▼
+2261.7% above sector average
Key checks
Key Insights
- 5-year CAGR of +15.9%, indicating consistent growth.
- In FY2025, income tax increased 0.0% year-over-year.
- Ranks #3 out of 204 companies in the Health Care sector.
- Peak income tax was recorded in FY2017.
Company context
Key Data Points
- Strong profit margin: 29.6%
- Strong return on equity: 36.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.8B | +0.0% |
| FY2024 | $2.8B | +85.4% |
| FY2023 | $1.5B | -21.2% |
| FY2022 | $1.9B | +26.1% |
| FY2021 | $1.5B | +13.5% |
| FY2020 | $1.3B | -14.4% |
| FY2019 | $1.6B | -37.6% |
| FY2018 | $2.5B | -38.9% |
| FY2017 | $4.1B | +471.4% |
| FY2016 | $718.0M | -23.8% |
As of FY2025 · SEC 10-K · Updated Mar 9, 2026